The Oncosearch | Oncotarget

MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma Research Paper

Fei Li, Yan Xu, Shuhui Deng, Zengjun Li, Dehui Zou, Shuhua Yi, Weiwei Sui, Mu Hao, Lugui Qiu

Published Oct 12, 2015 · Vol. 6, No. 35 · pp. 38270-38282

Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation Research Paper

Zhiqiang Liu, Jingda Xu, Jin He, Huan Liu, Pei Lin, Xinhai Wan, Nora M. Navone, Qiang Tong, Larry W. Kwak, Robert Z. Orlowski, Jing Yang

Published Oct 7, 2015 · Vol. 6, No. 33 · pp. 34329-34341

CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma Research Paper

Liang Zhang, Enguang Bi, Sungyoul Hong, Jianfei Qian, Chengyun Zheng, Michael Wang, Qing Yi

Published Oct 3, 2015 · Vol. 6, No. 34 · pp. 36032-36040

HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide Research Paper

Alessandro Canella, Hector Cordero Nieves, Douglas W. Sborov, Luciano Cascione, Hanna S. Radomska, Emily Smith, Andrew Stiff, Jessica Consiglio, Enrico Caserta, Lara Rizzotto, Nicola Zanesi, Volinia Stefano, Balveen Kaur, Xiaokui Mo, John C. Byrd, Yvonne A. Efebera, Craig C. Hofmeister, Flavia Pichiorri

Published Sep 25, 2015 · Vol. 6, No. 31 · pp. 31134-31150

Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment Research Paper

Xiaorong Sun, Ellen Ackerstaff, Fuqiu He, Ligang Xing, Hung Tsung Hsiao, Jason A. Koutcher, C. Clifton Ling, Gloria C. Li

Published Sep 23, 2015 · Vol. 6, No. 33 · pp. 34732-34744

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? Review

Reinaldo Franqui-Machin, Erik B. Wendlandt, Siegfried Janz, Fenghuang Zhan, Guido Tricot

Published Sep 22, 2015 · Vol. 6, No. 38 · pp. 40496-40506

Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH Research Paper

Meirong Zang, Dehui Zou, Zhen Yu, Fei Li, Shuhua Yi, Xiaofei Ai, Xiaoqi Qin, Xiaoyan Feng, Wen Zhou, Yan Xu, Zengjun Li, Mu Hao, Weiwei Sui, Shuhui Deng, Chirag Acharya, Yaozhong Zhao, Kun Ru, Lugui Qiu, Gang An

Published Sep 17, 2015 · Vol. 6, No. 33 · pp. 34276-34287

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation Research Paper

Derek James Hanson, Shingen Nakamura, Ryota Amachi, Masahiro Hiasa, Asuka Oda, Daisuke Tsuji, Kohji Itoh, Takeshi Harada, Kazuki Horikawa, Jumpei Teramachi, Hirokazu Miki, Toshio Matsumoto, Masahiro Abe

Published Sep 10, 2015 · Vol. 6, No. 32 · pp. 33568-33586

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I Research Paper

Guang Yang, Minjie Gao, Yiwen Zhang, Yuanyuan Kong, Lu Gao, Yi Tao, Ying Han, Huiqun Wu, Xiuqin Meng, Hongwei Xu, Fenghuang Zhan, Xiaosong Wu, Jumei Shi

Published Aug 20, 2015 · Vol. 6, No. 29 · pp. 26982-26994

Notch signaling deregulation in multiple myeloma: A rational molecular target Review

Michela Colombo, Serena Galletti, Silvia Garavelli, Natalia Platonova, Alessandro Paoli, Andrea Basile, Elisa Taiana, Antonino Neri, Raffaella Chiaramonte

Published Aug 13, 2015 · Vol. 6, No. 29 · pp. 26826-26840

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine Review

Mohamed R. Akl, Poonam Nagpal, Nehad M. Ayoub, Sathyen A. Prabhu, Matthew Gliksman, Betty Tai, Ahmet Hatipoglu, Andre Goy, K. Stephen Suh

Published Jul 22, 2015 · Vol. 6, No. 30 · pp. 28693-28715

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias Research Paper

Marta Lionetti, Marzia Barbieri, Katia Todoerti, Luca Agnelli, Sonia Fabris, Giovanni Tonon, Simona Segalla, Ingrid Cifola, Eva Pinatel, Pierfrancesco Tassone, Pellegrino Musto, Luca Baldini, Antonino Neri

Published Jul 20, 2015 · Vol. 6, No. 28 · pp. 26129-26141

Bortezomib inhibits Burkittâ€™s lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression Research Paper

Fat-Moon Suk, Shyr-Yi Lin, Ren-Jye Lin, Yung-Hsin Hsine, Yen-Ju Liao, Sheng-Uei Fang, Yu-Chih Liang

Published Jul 17, 2015 · Vol. 6, No. 28 · pp. 25988-26001

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma Research Paper

Charlotte KervoÃ«len, Emmanuelle MÃ©noret, Patricia Gomez-Bougie, RÃ©gis Bataille, Catherine Godon, SÃ©verine Marionneau-Lambot, Philippe Moreau, Catherine Pellat-Deceunynck, Martine Amiot

Published Jul 16, 2015 · Vol. 6, No. 29 · pp. 26922-26934

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model Research Paper

Cuiping Yang, Fei Xiong, Jun Dou, Jun Xue, Xi Zhan, Fangfang Shi, Miao Li, Songyan Wu, Shouhua Luo, Tianzhu Zhang, Yu Zhang, Ji Ming, Ning Gu

Published Jul 15, 2015 · Vol. 6, No. 29 · pp. 27714-27724

A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2 Research Paper

Andrew R. Lavik, Fei Zhong, Ming-Jin Chang, Edward Greenberg, Yuvraj Choudhary, Mitchell R. Smith, Karen S. McColl, John Pink, Frederic J. Reu, Shigemi Matsuyama, Clark W. Distelhorst

Published Jul 11, 2015 · Vol. 6, No. 29 · pp. 27388-27402

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma Research Paper

Chonglei Bi, Tae-Hoon Chung, Gaofeng Huang, Jianbiao Zhou, Junli J. Yan, Rafael Fonseca, Wee Joo Chng

Published Jul 3, 2015 · Vol. 6, No. 28 · pp. 26508-26518

Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma Research Paper

Min Wang, Ping Chen, Yan Jia, Na He, Daqi Li, Chunyan Ji, Daoxin Ma

Published Jun 25, 2015 · Vol. 6, No. 20 · pp. 17958-17967

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts Research Paper

Maria Rita Pitari, Marco Rossi, Nicola Amodio, Cirino Botta, Eugenio Morelli, Cinzia Federico, Annamaria GullÃ, Daniele Caracciolo, Maria Teresa Di Martino, Mariamena Arbitrio, Antonio Giordano, Pierosandro Tagliaferri, Pierfrancesco Tassone

Published Jun 24, 2015 · Vol. 6, No. 29 · pp. 27343-27358

Keywords: miR-21, miRNAs, Multiple Myeloma bone disease, OPG, RANKL

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma Research Paper

Cinzia Fionda, Maria Pia Abruzzese, Alessandra Zingoni, Francesca Cecere, Elisabetta Vulpis, Giovanna Peruzzi, Alessandra Soriani, Rosa Molfetta, Rossella Paolini, Maria Rosaria Ricciardi, Maria Teresa Petrucci, Angela Santoni, Marco Cippitelli

Published Jun 23, 2015 · Vol. 6, No. 27 · pp. 23609-23630

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma Research Paper

Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation Research Paper

CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma Research Paper

HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide Research Paper

Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment Research Paper

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? Review

Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH Research Paper

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation Research Paper

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I Research Paper

Notch signaling deregulation in multiple myeloma: A rational molecular target Review

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine Review

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias Research Paper

Bortezomib inhibits Burkittâ€™s lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression Research Paper

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma Research Paper

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model Research Paper

A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2 Research Paper

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma Research Paper

Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma Research Paper

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts Research Paper

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma Research Paper

Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation Research Paper

CD4+ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma Research Paper

HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide Research Paper

Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment Research Paper

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? Review

Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH Research Paper

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation Research Paper

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I Research Paper

Notch signaling deregulation in multiple myeloma: A rational molecular target Review

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine Review

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias Research Paper

Bortezomib inhibits Burkittâ€™s lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression Research Paper

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma Research Paper

Target therapy of multiple myeloma by PTX-NPs and ABCG2 antibody in a mouse xenograft model Research Paper

A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2 Research Paper

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma Research Paper

Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma Research Paper

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts Research Paper

The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma Research Paper

CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma Research Paper